表 1. Comparison of the baseline data of patients treated with three different endoscopic therapies.

3组不同治疗方式的基线资料比较

Item	Group 1 (n=22)	Group 2 (n=30)	Group 3 (n=21)	t/H/χ2	P
ALB: Albumin; HGB: Hemoglobin; PLT: Platelet; PT: Prothrombin time; INR: International normalized ratio; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; Cr: Creatinine. Group 1: Treated by only a cyanoacrylate mixture injection (including 2 mL lauromacrogol, 0.5 mL cyanoacrylate and 2 mL sodium chloride solution); Group 2: Treated by a cyanoacrylate mixture injection with the assistance of endoscopic clip; Group 3: Treated by a cyanoacrylate mixture injection with the assistance of endoscopic clip and LOOP.
Age/yr.,	56.27±13.70	60.23±9.81	59.86±9.53	0.919	0.404
ALB/(g/L),	32.77±6.48	33.64±7.99	30.46±5.03	1.380	0.258
HGB/(g/L),	83.17±23.08	89.67±24.89	84.95±19.15	0.572	0.567
PLT/×109 L−1, median (P25, P75)	77.20 (54.10, 133.50)	85.50 (49.40, 130.25)	94.00 (78.00, 132.50)	1.238	0.538
PT/s, median (P25, P75)	12.80 (11.7, 16.13)	13.65 (12.63, 15.70)	14.50 (13.75, 18.30)	5.210	0.740
INR (median [P25, P75])	1.32 (1.08, 1.60)	1.30 (1.17, 1.88)	1.34 (1.24, 1.59)	0.957	0.620
ALT/(U/L), median (P25, P75)	24.05 (9.98, 53.18)	19.95 (12.38, 30.38)	25.00 (20.35, 37.05)	1.707	0.426
AST/(U/L), median (P25, P75)	22.45 (14.90, 48.65)	22.65 (18.30, 31.40)	29.00 (17.10, 42.60)	0.590	0.744
Cr/(μmol/L), median (P25, P75)	58.50 (53.23, 67.83)	66.45 (56.35, 83.18)	69.40 (59.70, 76.55)	2.681	0.262
(Male/female)/case	13/9	11/19	11/20	2.790	0.248
(Child-Pugh A/B)/case	10/9	25/5	11/10	7.234	0.027
(Slpeno-renal/Gastro-renal/Compound shunt)/case	8/7/7	8/12/10	3/8/10	5.178	0.521
Thrombosis before therapy (yes/no)/case	0/22	1/29	2/19	8.841	0.031
Patient with hepatocellular carcinoma (yes/no)/case	0/22	1/29	4/17	7.097	0.029
Gastric varices hemorrhage before therapy (no/yes/unclear)/case	5/12/5	2/16/12	1/7/13	9.365	0.053